Cytokines such as IL-1, IL-6, TNF, and others (TGF-β, IL-22, IL-11) interact with cancer cells, promoting signaling pathways (e.g., IKK-NF-κB, JAK-STAT3, MAPK-AP1) that support cancer progression. This evidence concerns the gene IL22 and cancer.